Lancets Market size was valued at US$ 1141.70 Mn. in 2022 and the total revenue is expected to grow at a CAGR of 12.4% through 2022 to 2029, reaching nearly US$ 2587.72 Mn.Lancets Market Overview:
Blood is obtained using finger-stick blood samplers (lancet devices) for blood sugar testing (glucose). A "lancet holder," which resembles a little pen, and a lancet, which is the sharp point or needle that is placed in the holder, are the two pieces of these devices. The lancets are used only once. The Lancets Market is expected to reach at US$ 2,048.26 Mn. by 2029. Glucose Testing, Haemoglobin Testing, and Coagulation Testing are some of the applications of the Lancets.To know about the Research Methodology:- Request Free Sample Report
Lancets Market Dynamics:
Lancets are used for diabetes or glucose testing, baby tests, heel-stick screening tests, and scarred emergency patients or individuals who have been severely burned. The rising incidence rate of contagious and non-contagious diseases, the rising prevalence of diabetes, and the growing preference for home care and home diagnostics are all factors driving market growth. During the forecast period, however, the risk of blood transfusion and the poor reimbursement scenario in developing nations are expected to restrain market growth during the forecast period. The need for lancing devices is increasing due to the growing geriatric population and the increased frequency of chronic diseases. According to the World Health Organization, the global elderly population is expected to grow from 962 million in 2021 to 2.1 billion in 2050. The market is expected to be driven by rising government spending and technological improvements in the field of diabetes management. During the forecast period, the introduction of technologically sophisticated items and faster product approvals are expected to boost market growth. Diabetes management is a significant financial strain on economies and healthcare systems. Diabetes costs roughly USD 12 billion every year, according to the International Diabetes Federation (IDF), or 10% of the total yearly budget. Furthermore, technological advancements and the introduction of new products in the field of lancing devices are boosting lancets market growth during the forecast period. One of the most popular medical procedures is diagnostic blood testing, which accounts for 70-80% of all medical choices. Many businesses are developing new methods for collecting blood samples that are safer, easier, and more efficient. Due to features such as maximal skin-piercing force and minimal wound area, the introduction of high-speed lancing devices is driving market growth. Patients' pain is relieved, and recovery time is reduced, due to these devices.Lancets Market Segment Analysis:
Based on the Type, the market is segmented into Safety Lancets, and Personal Lancets. Safety Lancets segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2023-2029. Because of its advantages, such as ease of access, low cost, and low risk of infection Furthermore, in hospitals and clinics, safety lancets are the preferred choice for in-home diabetic monitoring. Safety lancets have the added virtue of being portable due to their exposed needles. Accidental sticks are avoided with the use of safety lancets. Infectious disease dissemination is less likely with retractable needles. For health care providers or family members who are testing blood glucose for someone else, this is a top priority. They're ideal for usage in doctor's offices, health fairs, public screenings, and school function screenings, as well as diabetes education programmes, clinic screenings, and hospital screenings, nursing homes, independent living health care centres, and home health care workers. Safety lancets obtain an adequate amount of blood with a single stick, which reduces strip waste, lowers expenses, and eliminates the need to re-prick your finger. Safety lancets have a fast speed, cause less pain, prevent errors, are ergonomically constructed, and have a nice grip. (It fits comfortably in the palm of the hand.) Because there is no needle loading and no exposed needle to dispose of, they are ideal for persons who are visually impaired. Based on the Application, the market is segmented into Blood Glucose Testing, Haemoglobin Testing, Coagulation Testing, and Other Applications. Blood Glucose Testing segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2023-2029. Because of the rising prevalence of diabetes and increased awareness of blood glucose self-monitoring. According to the International Diabetes Federation, roughly 463 million people worldwide suffer from diabetes, with that figure anticipated to rise to 700 million by 2050. The rising incidence of impaired blood glucose in both type 1 and type 2 patients is also contributing to the growth of the Blood Glucose Testing segment. Based on the End User, the market is segmented into Hospitals & Clinics, Home Care Settings, and Other End Users. Hospitals & Clinics segment is expected to hold the largest market share of xx% by 2029. This is due to factors such as the rising frequency of infectious diseases and the increased number of diabetic patients who require blood testing kits. Furthermore, the cost of diagnostic testing in the hospital is higher than homecare, resulting in higher market revenue. Home Care Settings segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2023-2029. The growth can be due to a variety of causes, including increased knowledge of blood glucose self-monitoring and the availability of numerous lancet devices on the market. Furthermore, because testing blood glucose levels at home is inexpensive, more patients are opting to monitor their blood glucose levels at home. Furthermore, improvements in patient self-care employing lancet devices around the world are driving segment growth during the forecast period.Lancets Market Regional Insights:
North America region is expected to dominate the Lancets market during the forecast period 2023-2029. North America region is expected to hold the largest market share of xx% by 2029. Because of the huge patient pool and excellent reimbursement policies in the North America region. The rising frequency of new product launches in the region, combined with rising healthcare expenditure, is driving market growth. According to the International Diabetes Federation, the region accounts for 43 percent of all diabetes-related health spending. Asia Pacific is expected to grow rapidly at a CAGR of xx% during the forecast period 2023-2029. This is due to improved healthcare infrastructure and the presence of a vast patient pool that requires a diagnostic test for treatment in this region. The demand for lancing devices is increasing as the incidence of infectious diseases such as dengue, Zika, West Nile, malaria, and chikungunya rises in the region. Furthermore, the rising COVID-19 outbreak in China is driving up need for diagnostic testing in the region. The objective of the report is to present a comprehensive analysis of the Global Lancets Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also help in understanding the Global Lancets Market dynamic, structure by analyzing the market segments and project the Global Lancets Market size. Clear representation of competitive analysis of key players by Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Lancets Market make the report investor’s guide.Lancets Market Scope: Inquire before buying
Global Lancets Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 1141.70 Mn. Forecast Period 2023 to 2029 CAGR: 12.4% Market Size in 2029: US $ 2587.72 Mn. Segments Covered: by Type Safety Lancets Personal Lancets by Application Blood Glucose Testing Haemoglobin Testing Coagulation Testing Other Applications by End User Hospitals & Clinics Home Care Settings Other End Users Lancets Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Lancets Market Key Players
1. Becton, Dickinson and Company 2. Roche Diagnostics 3. Ypsomed Holding 4. B. Braun Melsungen 5. Terumo Corporation 6. Owen Mumford 7. HTL-Strefa S.A 8. Arkray 9. Sarstedt 10.Sterilance Medical (Suzhou) 11.Medline Industries 12.Intrinsyk 13.I-SENS 14.Nipro 15.Omron 16.Infopia 17.Bayer AG 18.Abbott Laboratories Frequently Asked Questions: 1] Which region is expected to held the highest share in the Lancets Market? Ans. North America is expected to held the highest share in the Lancets Market. 2] Who are the top key players in the Lancets Market? Ans. Becton, Dickinson and Company, Roche Diagnostics, Ypsomed Holding, B. Braun Melsungen, and Terumo Corporation are the top key players in the Lancets Market. 3] Which segment holds the largest market share in the Lancets market by 2029? Ans. Hospitals & Clinics segment hold the largest market share in the Lancets market by 2029. 4] What is the market size of the Lancets market by 2029? Ans. The market size of the Lancets market is expected to reach US $ 2587.72 Mn. by 2029. 5] What was the market size of the Lancets market in 2022? Ans. The market size of the Lancets market was worth US $1141.70 Mn. in 2022.
1. Lancets Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Lancets Market: Dynamics 2.1. Lancets Market Trends by Region 2.1.1. North America Lancets Market Trends 2.1.2. Europe Lancets Market Trends 2.1.3. Asia Pacific Lancets Market Trends 2.1.4. Middle East and Africa Lancets Market Trends 2.1.5. South America Lancets Market Trends 2.2. Lancets Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Lancets Market Drivers 2.2.1.2. North America Lancets Market Restraints 2.2.1.3. North America Lancets Market Opportunities 2.2.1.4. North America Lancets Market Challenges 2.2.2. Europe 2.2.2.1. Europe Lancets Market Drivers 2.2.2.2. Europe Lancets Market Restraints 2.2.2.3. Europe Lancets Market Opportunities 2.2.2.4. Europe Lancets Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Lancets Market Drivers 2.2.3.2. Asia Pacific Lancets Market Restraints 2.2.3.3. Asia Pacific Lancets Market Opportunities 2.2.3.4. Asia Pacific Lancets Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Lancets Market Drivers 2.2.4.2. Middle East and Africa Lancets Market Restraints 2.2.4.3. Middle East and Africa Lancets Market Opportunities 2.2.4.4. Middle East and Africa Lancets Market Challenges 2.2.5. South America 2.2.5.1. South America Lancets Market Drivers 2.2.5.2. South America Lancets Market Restraints 2.2.5.3. South America Lancets Market Opportunities 2.2.5.4. South America Lancets Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Lancets Industry 2.8. Analysis of Government Schemes and Initiatives For Lancets Industry 2.9. Lancets Market Trade Analysis 2.10. The Global Pandemic Impact on Lancets Market 3. Lancets Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2022-2029 3.1. Lancets Market Size and Forecast, by Type (2022-2029) 3.1.1. Safety Lancets 3.1.2. Personal Lancets 3.2. Lancets Market Size and Forecast, by Application (2022-2029) 3.2.1. Blood Glucose Testing 3.2.2. Haemoglobin Testing 3.2.3. Coagulation Testing 3.2.4. Other Applications 3.3. Lancets Market Size and Forecast, by End Use (2022-2029) 3.3.1. Hospitals & Clinics 3.3.2. Home Care Settings 3.3.3. Other End Users 3.4. Lancets Market Size and Forecast, by Region (2022-2029) 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Middle East and Africa 3.4.5. South America 4. North America Lancets Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 4.1. North America Lancets Market Size and Forecast, by Type (2022-2029) 4.1.1. Safety Lancets 4.1.2. Personal Lancets 4.2. North America Lancets Market Size and Forecast, by Application (2022-2029) 4.2.1. Blood Glucose Testing 4.2.2. Haemoglobin Testing 4.2.3. Coagulation Testing 4.2.4. Other Applications 4.3. North America Lancets Market Size and Forecast, by End Use (2022-2029) 4.3.1. Hospitals & Clinics 4.3.2. Home Care Settings 4.3.3. Other End Users 4.4. North America Lancets Market Size and Forecast, by Country (2022-2029) 4.4.1. United States 4.4.1.1. United States Lancets Market Size and Forecast, by Type (2022-2029) 4.4.1.1.1. Safety Lancets 4.4.1.1.2. Personal Lancets 4.4.1.2. United States Lancets Market Size and Forecast, by Application (2022-2029) 4.4.1.2.1. Blood Glucose Testing 4.4.1.2.2. Haemoglobin Testing 4.4.1.2.3. Coagulation Testing 4.4.1.2.4. Other Applications 4.4.1.3. United States Lancets Market Size and Forecast, by End Use (2022-2029) 4.4.1.3.1. Hospitals & Clinics 4.4.1.3.2. Home Care Settings 4.4.1.3.3. Other End Users 4.4.2. Canada 4.4.2.1. Canada Lancets Market Size and Forecast, by Type (2022-2029) 4.4.2.1.1. Safety Lancets 4.4.2.1.2. Personal Lancets 4.4.2.2. Canada Lancets Market Size and Forecast, by Application (2022-2029) 4.4.2.2.1. Blood Glucose Testing 4.4.2.2.2. Haemoglobin Testing 4.4.2.2.3. Coagulation Testing 4.4.2.2.4. Other Applications 4.4.2.3. Canada Lancets Market Size and Forecast, by End Use (2022-2029) 4.4.2.3.1. Hospitals & Clinics 4.4.2.3.2. Home Care Settings 4.4.2.3.3. Other End Users 4.4.3. Mexico 4.4.3.1. Mexico Lancets Market Size and Forecast, by Type (2022-2029) 4.4.3.1.1. Safety Lancets 4.4.3.1.2. Personal Lancets 4.4.3.2. Mexico Lancets Market Size and Forecast, by Application (2022-2029) 4.4.3.2.1. Blood Glucose Testing 4.4.3.2.2. Haemoglobin Testing 4.4.3.2.3. Coagulation Testing 4.4.3.2.4. Other Applications 4.4.3.3. Mexico Lancets Market Size and Forecast, by End Use (2022-2029) 4.4.3.3.1. Hospitals & Clinics 4.4.3.3.2. Home Care Settings 4.4.3.3.3. Other End Users 5. Europe Lancets Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 5.1. Europe Lancets Market Size and Forecast, by Type (2022-2029) 5.2. Europe Lancets Market Size and Forecast, by Application (2022-2029) 5.3. Europe Lancets Market Size and Forecast, by End Use (2022-2029) 5.4. Europe Lancets Market Size and Forecast, by Country (2022-2029) 5.4.1. United Kingdom 5.4.1.1. United Kingdom Lancets Market Size and Forecast, by Type (2022-2029) 5.4.1.2. United Kingdom Lancets Market Size and Forecast, by Application (2022-2029) 5.4.1.3. United Kingdom Lancets Market Size and Forecast, by End Use(2022-2029) 5.4.2. France 5.4.2.1. France Lancets Market Size and Forecast, by Type (2022-2029) 5.4.2.2. France Lancets Market Size and Forecast, by Application (2022-2029) 5.4.2.3. France Lancets Market Size and Forecast, by End Use(2022-2029) 5.4.3. Germany 5.4.3.1. Germany Lancets Market Size and Forecast, by Type (2022-2029) 5.4.3.2. Germany Lancets Market Size and Forecast, by Application (2022-2029) 5.4.3.3. Germany Lancets Market Size and Forecast, by End Use (2022-2029) 5.4.4. Italy 5.4.4.1. Italy Lancets Market Size and Forecast, by Type (2022-2029) 5.4.4.2. Italy Lancets Market Size and Forecast, by Application (2022-2029) 5.4.4.3. Italy Lancets Market Size and Forecast, by End Use(2022-2029) 5.4.5. Spain 5.4.5.1. Spain Lancets Market Size and Forecast, by Type (2022-2029) 5.4.5.2. Spain Lancets Market Size and Forecast, by Application (2022-2029) 5.4.5.3. Spain Lancets Market Size and Forecast, by End Use (2022-2029) 5.4.6. Sweden 5.4.6.1. Sweden Lancets Market Size and Forecast, by Type (2022-2029) 5.4.6.2. Sweden Lancets Market Size and Forecast, by Application (2022-2029) 5.4.6.3. Sweden Lancets Market Size and Forecast, by End Use (2022-2029) 5.4.7. Austria 5.4.7.1. Austria Lancets Market Size and Forecast, by Type (2022-2029) 5.4.7.2. Austria Lancets Market Size and Forecast, by Application (2022-2029) 5.4.7.3. Austria Lancets Market Size and Forecast, by End Use (2022-2029) 5.4.8. Rest of Europe 5.4.8.1. Rest of Europe Lancets Market Size and Forecast, by Type (2022-2029) 5.4.8.2. Rest of Europe Lancets Market Size and Forecast, by Application (2022-2029) 5.4.8.3. Rest of Europe Lancets Market Size and Forecast, by End Use (2022-2029) 6. Asia Pacific Lancets Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 6.1. Asia Pacific Lancets Market Size and Forecast, by Type (2022-2029) 6.2. Asia Pacific Lancets Market Size and Forecast, by Application (2022-2029) 6.3. Asia Pacific Lancets Market Size and Forecast, by End Use (2022-2029) 6.4. Asia Pacific Lancets Market Size and Forecast, by Country (2022-2029) 6.4.1. China 6.4.1.1. China Lancets Market Size and Forecast, by Type (2022-2029) 6.4.1.2. China Lancets Market Size and Forecast, by Application (2022-2029) 6.4.1.3. China Lancets Market Size and Forecast, by End Use (2022-2029) 6.4.2. S Korea 6.4.2.1. S Korea Lancets Market Size and Forecast, by Type (2022-2029) 6.4.2.2. S Korea Lancets Market Size and Forecast, by Application (2022-2029) 6.4.2.3. S Korea Lancets Market Size and Forecast, by End Use (2022-2029) 6.4.3. Japan 6.4.3.1. Japan Lancets Market Size and Forecast, by Type (2022-2029) 6.4.3.2. Japan Lancets Market Size and Forecast, by Application (2022-2029) 6.4.3.3. Japan Lancets Market Size and Forecast, by End Use (2022-2029) 6.4.4. India 6.4.4.1. India Lancets Market Size and Forecast, by Type (2022-2029) 6.4.4.2. India Lancets Market Size and Forecast, by Application (2022-2029) 6.4.4.3. India Lancets Market Size and Forecast, by End Use (2022-2029) 6.4.5. Australia 6.4.5.1. Australia Lancets Market Size and Forecast, by Type (2022-2029) 6.4.5.2. Australia Lancets Market Size and Forecast, by Application (2022-2029) 6.4.5.3. Australia Lancets Market Size and Forecast, by End Use (2022-2029) 6.4.6. Indonesia 6.4.6.1. Indonesia Lancets Market Size and Forecast, by Type (2022-2029) 6.4.6.2. Indonesia Lancets Market Size and Forecast, by Application (2022-2029) 6.4.6.3. Indonesia Lancets Market Size and Forecast, by End Use (2022-2029) 6.4.7. Malaysia 6.4.7.1. Malaysia Lancets Market Size and Forecast, by Type (2022-2029) 6.4.7.2. Malaysia Lancets Market Size and Forecast, by Application (2022-2029) 6.4.7.3. Malaysia Lancets Market Size and Forecast, by End Use (2022-2029) 6.4.8. Vietnam 6.4.8.1. Vietnam Lancets Market Size and Forecast, by Type (2022-2029) 6.4.8.2. Vietnam Lancets Market Size and Forecast, by Application (2022-2029) 6.4.8.3. Vietnam Lancets Market Size and Forecast, by End Use(2022-2029) 6.4.9. Taiwan 6.4.9.1. Taiwan Lancets Market Size and Forecast, by Type (2022-2029) 6.4.9.2. Taiwan Lancets Market Size and Forecast, by Application (2022-2029) 6.4.9.3. Taiwan Lancets Market Size and Forecast, by End Use (2022-2029) 6.4.10. Rest of Asia Pacific 6.4.10.1. Rest of Asia Pacific Lancets Market Size and Forecast, by Type (2022-2029) 6.4.10.2. Rest of Asia Pacific Lancets Market Size and Forecast, by Application (2022-2029) 6.4.10.3. Rest of Asia Pacific Lancets Market Size and Forecast, by End Use (2022-2029) 7. Middle East and Africa Lancets Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 7.1. Middle East and Africa Lancets Market Size and Forecast, by Type (2022-2029) 7.2. Middle East and Africa Lancets Market Size and Forecast, by Application (2022-2029) 7.3. Middle East and Africa Lancets Market Size and Forecast, by End Use (2022-2029) 7.4. Middle East and Africa Lancets Market Size and Forecast, by Country (2022-2029) 7.4.1. South Africa 7.4.1.1. South Africa Lancets Market Size and Forecast, by Type (2022-2029) 7.4.1.2. South Africa Lancets Market Size and Forecast, by Application (2022-2029) 7.4.1.3. South Africa Lancets Market Size and Forecast, by End Use (2022-2029) 7.4.2. GCC 7.4.2.1. GCC Lancets Market Size and Forecast, by Type (2022-2029) 7.4.2.2. GCC Lancets Market Size and Forecast, by Application (2022-2029) 7.4.2.3. GCC Lancets Market Size and Forecast, by End Use (2022-2029) 7.4.3. Nigeria 7.4.3.1. Nigeria Lancets Market Size and Forecast, by Type (2022-2029) 7.4.3.2. Nigeria Lancets Market Size and Forecast, by Application (2022-2029) 7.4.3.3. Nigeria Lancets Market Size and Forecast, by End Use (2022-2029) 7.4.4. Rest of ME&A 7.4.4.1. Rest of ME&A Lancets Market Size and Forecast, by Type (2022-2029) 7.4.4.2. Rest of ME&A Lancets Market Size and Forecast, by Application (2022-2029) 7.4.4.3. Rest of ME&A Lancets Market Size and Forecast, by End Use (2022-2029) 8. South America Lancets Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 8.1. South America Lancets Market Size and Forecast, by Type (2022-2029) 8.2. South America Lancets Market Size and Forecast, by Application (2022-2029) 8.3. South America Lancets Market Size and Forecast, by End Use(2022-2029) 8.4. South America Lancets Market Size and Forecast, by Country (2022-2029) 8.4.1. Brazil 8.4.1.1. Brazil Lancets Market Size and Forecast, by Type (2022-2029) 8.4.1.2. Brazil Lancets Market Size and Forecast, by Application (2022-2029) 8.4.1.3. Brazil Lancets Market Size and Forecast, by End Use (2022-2029) 8.4.2. Argentina 8.4.2.1. Argentina Lancets Market Size and Forecast, by Type (2022-2029) 8.4.2.2. Argentina Lancets Market Size and Forecast, by Application (2022-2029) 8.4.2.3. Argentina Lancets Market Size and Forecast, by End Use (2022-2029) 8.4.3. Rest Of South America 8.4.3.1. Rest Of South America Lancets Market Size and Forecast, by Type (2022-2029) 8.4.3.2. Rest Of South America Lancets Market Size and Forecast, by Application (2022-2029) 8.4.3.3. Rest Of South America Lancets Market Size and Forecast, by End Use (2022-2029) 9. Global Lancets Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Lancets Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Becton, Dickinson and Company 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Roche Diagnostics 10.3. Ypsomed Holding 10.4. B. Braun Melsungen 10.5. Terumo Corporation 10.6. Owen Mumford 10.7. HTL-Strefa S.A 10.8. Arkray 10.9. Sarstedt 10.10. Sterilance Medical (Suzhou) 10.11. Medline Industries 10.12. Intrinsyk 10.13. I-SENS 10.14. Nipro 10.15. Omron 10.16. Infopia 10.17. Bayer AG 10.18. Abbott Laboratories 11. Key Findings 12. Industry Recommendations 13. Lancets Market: Research Methodology 14. Terms and Glossary